The association between PIK3CA mutations and TNBC subtypes is a pivotal aspect of molecular characterization, shedding light on the intricate heterogeneity within this aggressive breast cancer category [15,[35], [36], [37]]. The gene discussed is PIK3CA; the disease is breast cancer.